Statin-Associated Muscle Symptoms

Paul D. Thompson, Beth A. Taylor (Herausgeber)

Buch | Softcover

XI, 188 Seiten

2021 | 1st ed. 2020
Springer International Publishing (Verlag)
978-3-030-33306-5 (ISBN)

Artikel merken

This book provides an overview of statin-associated muscle symptoms (SAMS) from clinical presentation to treatment and possible metabolic causes. It examines the risk factors, presentations, diagnosis and differential diagnosis, clinical management, and financial costs of SAMS. The book also highlights patients' perspectives on SAMS such as the psychosocial, emotional, and societal factors influencing their perceptions and experiences. Finally, the book presents the results of observational and clinical trials on the prevalence of SAMS, clinical trials for treatments, and potential future research approaches for improving the understanding and treatment of SAMS. A key addition to the Contemporary Cardiology series, Statin-Associated Muscle Symptoms is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in cardiology, endocrinology, pharmacotherapy, primary care, and health promotion and disease prevention.

Paul D. Thompson, MDChief of Cardiology EmeritusHartford HospitalHartford, CTProfessor of MedicineUniversity of Connecticut School of MedicineFarmington, CT Beth A. Taylor, PhDDivision of CardiologyHartford HospitalHartford, CTDepartment of KinesiologyUniversity of ConnecticutStorrs, CT

Chapter 1. Introduction.- Chapter 2. Do Statin-Associated Muscle Symptoms (SAMS) Exist?.- Chapter 3. The Clinical Presentation of SAMS.- Chapter 4. Definitions of SAMS.- Chapter 5. The Patient's Perspective of SAMS.- Chapter 6. Psychosocial, Emotional, and Societal Factors Influencing Perceptions and Experiences of SAMS.- Chapter 7. Prevalence of SAMS in Observational and Clinical Trials.- Chapter 8. Risk factors for SAMS.- Chapter 9. Clinical Trials of Treatments for SAMS.- Chapter 10. Clinical Management of SAMS.- Chapter 11. Effects of Statins on Exercise Performance and Exercise Training.- Chapter 12. Genetic Risk Factors for SAMS.- Chapter 13. The Role of the Mitochondria in SAMS.- Chapter 14. The Role of Energy Metabolism in SAMS.- Chapter 15. Vitamin D and SAMS.- Chapter 16. Coenzyme Q 10 and SAMS.- Chapter 17. Diagnosing SAMS.- Chapter 18. The Clinical and Financial Cost of SAMS.- Chapter19. The Interaction of Statins and Inherited Muscle Disease.- Chapter 20. The Differential Diagnosis of SAMS.- Chapter 21. Statin-Associated Inflammatory Myositis and Other Inflammatory Conditions.- Chapter 22. Managing Statin Rhabdomyolysis.- Chapter 23. Future Directions: Critical Questions and Research Approaches to Improving Understanding and Treatment of SAMS.

Erscheinungsdatum	27.01.2021
Reihe/Serie	Contemporary Cardiology
Zusatzinfo	XI, 188 p. 22 illus., 16 illus. in color.
Verlagsort	Cham
Sprache	englisch
Maße	178 x 254 mm
Gewicht	435 g
Themenwelt	Medizinische Fachgebiete ► Innere Medizin ► Endokrinologie
	Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie
	Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie
Schlagworte	Clinical management of statin-associated muscle symptoms • Clinical presentations of statin-associated muscle symptoms • Clinical trials on statin-associated muscle symptoms • Diagnosis of statin-associated muscle symptoms • Patients' perceptions and experiences of SAMS • Patients’ perceptions and experiences of SAMS • pharmacotherapy • Prevalence of statin-associated muscle symptoms • Risk factors for statin-associated muscle symptoms • Statin-associated inflammatory myositis • Statins and exercise performance • Treatment of statin-associated muscle symptoms
ISBN-10	3-030-33306-X / 303033306X
ISBN-13	978-3-030-33306-5 / 9783030333065
Zustand	Neuware